Howard Robin

Howard Robin

Chief Executive Officer at NEKTAR THERAPEUTICS

Net worth: 4 M $ as of 2026-06-29

73 year
Health Technology
Commercial Services
Consumer Services

Profile

Howard W.
Robin
is President, Chief Executive Officer & Director at Nektar Therapeutics since 2007.
Formerly, Mr. Robin was President, Chief Executive Officer & Director at Sirna Therapeutics, Inc. from 2001 to 2006.
From 1984 to 2001, held roles at Berlex, Inc., including Director-Business Planning & Development from 1987 to 2001 and Vice President & General Manager from 1991 to 2001.
Also served as Director at Acologix, Inc., Biotechnology Innovation Organization, and The Bay Area Bioscience Association.
Worked as Senior Associate at Arthur Andersen LLP.
Served as Trustee at Fairleigh Dickinson University.
Education includes an undergraduate degree from Fairleigh Dickinson University, conferred in 1974.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-07-23 55,073 ( 0.16% ) 4 M $ 2026-06-29

Howard Robin active positions

CompaniesPositionStart
NEKTAR THERAPEUTICS Chief Executive Officer 2006-12-31

Former positions of Howard Robin

CompaniesPositionEnd
Chief Executive Officer 2006-10-31
Corporate Officer/Principal -
Berlex Laboratories, Inc.
Director of Finance/CFO 1990-12-31
Director/Board Member -
Director/Board Member -
See the detail of Howard Robin's experience

Training of Howard Robin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

76

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Commercial Services

Consumer Services

Health Technology

Berlex Laboratories, Inc.

Health Technology